References
References
1. Schade DS, Eaton RP. Metabolic and clinical significance of
ketosis. Special Topics in Endocrinology and Metabolism 1982;
4:1–27.
2. Wiggam MI, O’Kane MJ, Harper R, Atkinson AB, Hadden DR,
Trimble ER, Bell PM. Treatment of diabetic ketoacidosis using
normalization of blood
3-hydroxybutyrate concentration as the endpoint of emergency
management. Diabetes Care 1997; 20:1347–52.
3. Harano Y, Kosugi K, Hyosu T, Suzuki M, Hidaka H, Kashiwagi A,
Uno S, Shigeta Y. Ketone bodies as markers for Type 1 (insulin-
dependent) diabetes and their value in the monitoring of
diabetes control. Diabetologia 1984; 26:343–8.
4. Ubukata E. Diurnal variation of blood
β-Ketone bodies in
insulin-dependent diabetes mellitus and non-insulin-dependent
diabetes mellitus patients: The relationship to serum C-peptide
immunoreactivity and free insulin. Ann Nutr Metab 1990;
34:333–42.
5. Luzi L, Barrett EJ, Groop LC, Ferrannini E, DeFronzo RA. Metabolic
effects of low-dose insulin therapy on glucose metabolism in
diabetic ketoacidosis. Diabetes 1988; 37:1470–77.
6. Hale PJ, Crase J, Nattrass M. Metabolic effects of bicarbonate
in the treatment of diabetic ketoacidosis. Br Med J 1984;
289; 1035–8.
57
To Next Page
Loading...
